Gold forecast intact as safe-haven appeal remains unabated amid Fed easing and the ongoing US government shutdown.

Eli Lilly's stock shows robust momentum and strong analyst support, driven by solid fundamentals and positive market sentiment, while upcoming earnings releases remain a focal point for investors.

The S&P 500 finds itself at a crossroads, buffeted by conflicting signals as markets parse fresh macro and corporate cues.